MedTrace Logo

Pre-Salpingo-Oophorectomy Pilot Study of MAKO 7 Device Performance

NCT02974842 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2020-04-21

Study results available
· View outcomes & findings →

Summary

This study evaluates the ability of the MAKO 7 device to collect various cells

Conditions

  • BRCA1 Mutation
  • BRCA2 Mutation
  • Atypia Suspicious for Malignancy

Interventions

DEVICE

MAKO 7

Hysteroscopic cell sampling

Sponsors & Collaborators

  • nVision Medical

    lead INDUSTRY

Principal Investigators

  • Surbhi Sarna, B.S. · nVision Medical Corp

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-02
Primary Completion
2017-09-27
Completion
2017-09-27

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02974842 on ClinicalTrials.gov